PRLD
Price
$2.23
Change
-$0.01 (-0.45%)
Updated
Feb 13 closing price
Capitalization
140.82M
31 days until earnings call
Intraday BUY SELL Signals
RNTX
Price
$1.12
Change
-$0.05 (-4.27%)
Updated
Feb 13 closing price
Capitalization
28.65M
Intraday BUY SELL Signals
Interact to see
Advertisement

PRLD vs RNTX

Header iconPRLD vs RNTX Comparison
Open Charts PRLD vs RNTXBanner chart's image
Prelude Therapeutics
Price$2.23
Change-$0.01 (-0.45%)
Volume$127.07K
Capitalization140.82M
Rein Therapeutics
Price$1.12
Change-$0.05 (-4.27%)
Volume$84.75K
Capitalization28.65M
PRLD vs RNTX Comparison Chart in %
PRLD
Daily Signal:
Gain/Loss:
RNTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
PRLD vs. RNTX commentary
Feb 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRLD is a Hold and RNTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 15, 2026
Stock price -- (PRLD: $2.23 vs. RNTX: $1.12)
Brand notoriety: PRLD and RNTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRLD: 28% vs. RNTX: 47%
Market capitalization -- PRLD: $140.82M vs. RNTX: $28.65M
PRLD [@Biotechnology] is valued at $140.82M. RNTX’s [@Biotechnology] market capitalization is $28.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $124.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRLD’s FA Score shows that 0 FA rating(s) are green whileRNTX’s FA Score has 0 green FA rating(s).

  • PRLD’s FA Score: 0 green, 5 red.
  • RNTX’s FA Score: 0 green, 5 red.
According to our system of comparison, PRLD is a better buy in the long-term than RNTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRLD’s TA Score shows that 6 TA indicator(s) are bullish while RNTX’s TA Score has 3 bullish TA indicator(s).

  • PRLD’s TA Score: 6 bullish, 3 bearish.
  • RNTX’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, PRLD is a better buy in the short-term than RNTX.

Price Growth

PRLD (@Biotechnology) experienced а +2.76% price change this week, while RNTX (@Biotechnology) price change was -1.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.41%. For the same industry, the average monthly price growth was -4.89%, and the average quarterly price growth was +22.89%.

Reported Earning Dates

PRLD is expected to report earnings on Mar 18, 2026.

Industries' Descriptions

@Biotechnology (+2.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRLD($141M) has a higher market cap than RNTX($28.7M). RNTX YTD gains are higher at: -3.448 vs. PRLD (-23.103). RNTX has higher annual earnings (EBITDA): -23.77M vs. PRLD (-119.27M). PRLD has more cash in the bank: 55M vs. RNTX (4.05M). PRLD has higher revenues than RNTX: PRLD (10.5M) vs RNTX (0).
PRLDRNTXPRLD / RNTX
Capitalization141M28.7M491%
EBITDA-119.27M-23.77M502%
Gain YTD-23.103-3.448670%
P/E RatioN/AN/A-
Revenue10.5M0-
Total Cash55M4.05M1,359%
Total Debt17.9MN/A-
FUNDAMENTALS RATINGS
RNTX: Fundamental Ratings
RNTX
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
40

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PRLDRNTX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
87%
Bullish Trend 20 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
PRLD
Daily Signal:
Gain/Loss:
RNTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RAIL13.240.40
+3.12%
FreightCar America
BSX74.730.61
+0.82%
Boston Scientific Corp
HOMB29.35-0.12
-0.41%
Home BancShares
DAIO2.90-0.15
-4.92%
Data I/O Corp
NVCR10.99-1.54
-12.29%
NovoCure Limited

PRLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRLD has been loosely correlated with IPSC. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if PRLD jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRLD
1D Price
Change %
PRLD100%
-0.45%
IPSC - PRLD
54%
Loosely correlated
N/A
IMNM - PRLD
54%
Loosely correlated
-1.25%
INBX - PRLD
53%
Loosely correlated
-7.68%
TRDA - PRLD
52%
Loosely correlated
+0.74%
ANNX - PRLD
52%
Loosely correlated
-5.78%
More

RNTX and

Correlation & Price change

A.I.dvisor tells us that RNTX and NNVC have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RNTX and NNVC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNTX
1D Price
Change %
RNTX100%
-4.27%
NNVC - RNTX
26%
Poorly correlated
+7.53%
PRLD - RNTX
26%
Poorly correlated
-0.45%
VSTM - RNTX
26%
Poorly correlated
-0.34%
GNTA - RNTX
25%
Poorly correlated
-1.12%
IKT - RNTX
25%
Poorly correlated
+1.83%
More